UniProt ID | TEBP_HUMAN | |
---|---|---|
UniProt AC | Q15185 | |
Protein Name | Prostaglandin E synthase 3 | |
Gene Name | PTGES3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 160 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2). [PubMed: 10922363 Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes] | |
Protein Sequence | MQPASAKWYDRRDYVFIEFCVEDSKDVNVNFEKSKLTFSCLGGSDNFKHLNEIDLFHCIDPNDSKHKRTDRSILCCLRKGESGQSWPRLTKERAKLNWLSVDFNNWKDWEDDSDEDMSNFDRFSEMMNNMGGDEDVDLPEVDGADDDSQDSDDEKMPDLE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MQPASAKW -------CCCCCCCC | 10.99 | - | |
7 | Acetylation | -MQPASAKWYDRRDY -CCCCCCCCCCCCCE | 43.73 | 23954790 | |
7 | Ubiquitination | -MQPASAKWYDRRDY -CCCCCCCCCCCCCE | 43.73 | 21890473 | |
7 | Ubiquitination | -MQPASAKWYDRRDY -CCCCCCCCCCCCCE | 43.73 | 21890473 | |
7 | Ubiquitination | -MQPASAKWYDRRDY -CCCCCCCCCCCCCE | 43.73 | 21890473 | |
7 | Ubiquitination | -MQPASAKWYDRRDY -CCCCCCCCCCCCCE | 43.73 | 21890473 | |
14 | Phosphorylation | KWYDRRDYVFIEFCV CCCCCCCEEEEEEEE | 8.75 | 22817900 | |
24 | Phosphorylation | IEFCVEDSKDVNVNF EEEEEECCCCCEEEE | 19.76 | 29759185 | |
33 | Malonylation | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 26320211 | |
33 | Ubiquitination | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 21890473 | |
33 | Sumoylation | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 19608861 | |
33 | Ubiquitination | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 21890473 | |
33 | Ubiquitination | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 21890473 | |
33 | Methylation | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 19608861 | |
33 | Acetylation | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 19608861 | |
33 | Sumoylation | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | - | |
33 | Ubiquitination | DVNVNFEKSKLTFSC CCEEEEEECCEEEEE | 49.07 | 21906983 | |
34 | Phosphorylation | VNVNFEKSKLTFSCL CEEEEEECCEEEEEC | 26.21 | 28450419 | |
35 | Sumoylation | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | - | |
35 | Ubiquitination | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 21890473 | |
35 | Ubiquitination | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 21890473 | |
35 | Sumoylation | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 28112733 | |
35 | Acetylation | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 23749302 | |
35 | Ubiquitination | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 21890473 | |
35 | Ubiquitination | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | 21890473 | |
35 | Acetylation | NVNFEKSKLTFSCLG EEEEEECCEEEEECC | 63.72 | - | |
37 | Phosphorylation | NFEKSKLTFSCLGGS EEEECCEEEEECCCC | 19.76 | 28450419 | |
39 | Phosphorylation | EKSKLTFSCLGGSDN EECCEEEEECCCCCC | 11.82 | 29255136 | |
40 | S-nitrosocysteine | KSKLTFSCLGGSDNF ECCEEEEECCCCCCC | 3.41 | - | |
40 | S-nitrosylation | KSKLTFSCLGGSDNF ECCEEEEECCCCCCC | 3.41 | 19483679 | |
40 | Glutathionylation | KSKLTFSCLGGSDNF ECCEEEEECCCCCCC | 3.41 | 22555962 | |
44 | Phosphorylation | TFSCLGGSDNFKHLN EEEECCCCCCCCCCC | 27.81 | 29255136 | |
48 | Acetylation | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | - | |
48 | Ubiquitination | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | 21890473 | |
48 | Ubiquitination | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | 21890473 | |
48 | Methylation | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | 71275 | |
48 | Acetylation | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | 23749302 | |
48 | Ubiquitination | LGGSDNFKHLNEIDL CCCCCCCCCCCCEEE | 54.13 | 21906983 | |
58 | Glutathionylation | NEIDLFHCIDPNDSK CCEEEEEEECCCCCC | 2.71 | 22555962 | |
64 | Phosphorylation | HCIDPNDSKHKRTDR EEECCCCCCCCCCCC | 43.21 | 28450419 | |
65 | Ubiquitination | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | 21890473 | |
65 | Ubiquitination | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | 21890473 | |
65 | 2-Hydroxyisobutyrylation | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | - | |
65 | Sumoylation | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | - | |
65 | Ubiquitination | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | 21906983 | |
65 | Sumoylation | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | 28112733 | |
65 | Acetylation | CIDPNDSKHKRTDRS EECCCCCCCCCCCCE | 56.88 | 25953088 | |
67 | Ubiquitination | DPNDSKHKRTDRSIL CCCCCCCCCCCCEEE | 61.81 | - | |
67 | Ubiquitination | DPNDSKHKRTDRSIL CCCCCCCCCCCCEEE | 61.81 | - | |
69 | Phosphorylation | NDSKHKRTDRSILCC CCCCCCCCCCEEEEE | 40.34 | 23312004 | |
72 | Phosphorylation | KHKRTDRSILCCLRK CCCCCCCEEEEEEEC | 23.79 | 20873877 | |
75 | S-nitrosocysteine | RTDRSILCCLRKGES CCCCEEEEEEECCCC | 1.64 | - | |
75 | S-palmitoylation | RTDRSILCCLRKGES CCCCEEEEEEECCCC | 1.64 | 29575903 | |
75 | S-nitrosylation | RTDRSILCCLRKGES CCCCEEEEEEECCCC | 1.64 | 19483679 | |
76 | S-nitrosylation | TDRSILCCLRKGESG CCCEEEEEEECCCCC | 3.55 | 19483679 | |
76 | S-palmitoylation | TDRSILCCLRKGESG CCCEEEEEEECCCCC | 3.55 | 29575903 | |
76 | S-nitrosocysteine | TDRSILCCLRKGESG CCCEEEEEEECCCCC | 3.55 | - | |
79 | Ubiquitination | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | 21890473 | |
79 | Ubiquitination | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | 21890473 | |
79 | Acetylation | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | 26051181 | |
79 | Sumoylation | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | - | |
79 | Sumoylation | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | - | |
79 | Ubiquitination | SILCCLRKGESGQSW EEEEEEECCCCCCCC | 54.82 | 21890473 | |
82 | Phosphorylation | CCLRKGESGQSWPRL EEEECCCCCCCCCCC | 51.29 | 23927012 | |
85 | Phosphorylation | RKGESGQSWPRLTKE ECCCCCCCCCCCCHH | 42.44 | 23401153 | |
90 | Phosphorylation | GQSWPRLTKERAKLN CCCCCCCCHHHHHCC | 31.94 | 29514088 | |
91 | Ubiquitination | QSWPRLTKERAKLNW CCCCCCCHHHHHCCE | 50.20 | - | |
91 | Acetylation | QSWPRLTKERAKLNW CCCCCCCHHHHHCCE | 50.20 | 11921337 | |
95 | Sumoylation | RLTKERAKLNWLSVD CCCHHHHHCCEEEEC | 48.88 | - | |
95 | Ubiquitination | RLTKERAKLNWLSVD CCCHHHHHCCEEEEC | 48.88 | 21890473 | |
95 | Sumoylation | RLTKERAKLNWLSVD CCCHHHHHCCEEEEC | 48.88 | - | |
95 | Ubiquitination | RLTKERAKLNWLSVD CCCHHHHHCCEEEEC | 48.88 | 21890473 | |
100 | Phosphorylation | RAKLNWLSVDFNNWK HHHCCEEEECCCCCC | 15.97 | 22617229 | |
113 (in isoform 4) | Phosphorylation | - | 56.04 | 25849741 | |
113 | Phosphorylation | WKDWEDDSDEDMSNF CCCCCCCCCCCCCHH | 56.04 | 19664994 | |
118 (in isoform 3) | Phosphorylation | - | 46.82 | 22210691 | |
118 | Phosphorylation | DDSDEDMSNFDRFSE CCCCCCCCHHHHHHH | 46.82 | 22167270 | |
118 (in isoform 4) | Phosphorylation | - | 46.82 | 25849741 | |
121 (in isoform 3) | Phosphorylation | - | 55.77 | 22210691 | |
124 (in isoform 4) | Phosphorylation | - | 26.02 | 23663014 | |
124 | Phosphorylation | MSNFDRFSEMMNNMG CCHHHHHHHHHHHCC | 26.02 | 23927012 | |
127 (in isoform 4) | Phosphorylation | - | 2.62 | 26055452 | |
130 (in isoform 4) | Phosphorylation | - | 5.58 | 25159151 | |
148 | Phosphorylation | VDGADDDSQDSDDEK CCCCCCCCCCCCCCC | 42.77 | 23927012 | |
151 | Phosphorylation | ADDDSQDSDDEKMPD CCCCCCCCCCCCCCC | 39.05 | 23927012 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TEBP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TEBP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1; LYS-7 AND LYS-33, ANDMASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 ANDSER-151, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148 AND SER-151, ANDMASS SPECTROMETRY. | |
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-118; SER-148AND SER-151, AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. |